Metis Global Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Metis Global Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$982K	Buy	28,999 +4,844	+20%	+$161K	0.02%	445
2026 Q1	$728K	Buy	24,155 +1,822	+8%	+$58.6K	0.02%	511
2025 Q4	$697K	Buy	22,333 +6,084	+37%	+$150K	0.02%	531
2025 Q3	$328K	Buy	16,249 +848	+6%	+$14.9K	0.01%	653
2025 Q2	$258K	Buy	15,401 +1,749	+13%	+$28.2K	0.01%	672
2025 Q1	$210K	Sell	13,652 -45	-0.3%	-$804	0.01%	724
2024 Q4	$302K	Buy	13,697 +860	+7%	+$15.6K	0.01%	665
2024 Q3	$231K	Buy	12,837 +359	+3%	+$6.28K	0.01%	709
2024 Q2	$203K	Buy	+12,478	New	+$192K	0.01%	720

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Metis Global Partners's TEVA Position: Q2 2026 in Review

Metis Global Partners increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 20% in Q2 2026, buying an estimated $161K and bringing the position to 28,999 shares worth $982K. The position accounts for 0.02% of the portfolio, ranked #445.

Metis Global Partners first reported a position in TEVA in Q2 2024 and has held it in 9 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Metis Global Partners held 28,999 shares of Teva Pharmaceutical Industries Limited worth $982K as of Q2 2026.
Metis Global Partners bought 4,844 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $161K.
Teva Pharmaceutical Industries Limited made up 0.02% of Metis Global Partners's portfolio in Q2 2026, its #445 holding.
Metis Global Partners first reported a position in Teva Pharmaceutical Industries Limited in Q2 2024 and has held it in 9 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.